Nationales Centrum für Tumorerkrankungen (NCT)
Research facility
Location:
Heidelberg, Dresden, Berlin, Essen, Köln, Würzburg, Erlangen, Regensburg, Augsburg, Tübingen, Stuttgart, Ulm,
Germany (DE)
ISNI: 0000000088550365
ROR: https://ror.org/01txwsw02
Show on Map:
Prevention and management of adverse events of novel agents in multiple myeloma: A consensus of the European Myeloma Network (2018)
Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, et al.
Journal article, Review article
Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup (2018)
Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, et al.
Journal article
Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe (2017)
Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pfoehler C, Kellner I, et al.
Journal article
Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society (2017)
Kowalski C, Graeven U, Von Kalle C, Lang H, Beckmann M, Blohmer JU, Burchardt M, et al.
Journal article
Advanced-stage pancreatic cancer: Therapy options (2013)
Werner J, Combs SE, Springfeld C, Hartwig W, Hackert T, Buechler MW
Journal article, Review article